Skip to content

Cognitive and Brain Development in Adolescents With Gilles de la Tourette Syndrome

Développement Cognitif et cérébral Chez Les Adolescents Souffrants d'un Syndrome de Gilles de la Tourette

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04179435
Acronym
CADETS
Enrollment
132
Registered
2019-11-27
Start date
2019-12-11
Completion date
2024-06-18
Last updated
2026-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tourette Syndrome in Adolescence

Brief summary

In children with neurodevelopmental disorders, adolescence is usually associated with a reshaping of the clinical picture and symptomatology. Tourette syndrome (TS) is a paradigmal neurodevelopmental syndrome characterised by involuntary paroxysmal movements (motor tics) and vocalisation (vocal tics) often associated with various psychiatric disorders. The neuronal and cognitive mechanisms associated with TS symptoms improvement during adolescence, or the persistence in adulthood remains unknown, and this is what we aim to address in this study.

Detailed description

Thus, the aims of the present project is threefold: Aim 1: To evaluate the maturation of cognitive functions in adolescents with TS compared to typically developing adolescents. To achieve this aim, three distinct cognitive dimensions will be assessed in all subjects (patients and controls): (i) reward sensitivity and habit formation; (ii) cognitive impulsivity and action control and (iii) self-agency. Aim 2: To identify neuronal correlates of cognitive function and brain development in health and disease. To achieve this aim, we will use a combined behavioural (as described in Aim 1), (i) neuroimaging and (ii) TMS approaches. Aim 3: To predict clinical outcome . In this part of the project we aim to identify behavioural, imaging or neurophysiological markers of clinical outcome in patients with TS.

Interventions

BEHAVIORALBehavioral testing on cognitive computerized tasks

Testing on cognitive computerized tasks

OTHERbrain MRI

Brain MRI scans

OTHERTMS

Measure of the cortical inhibitory capacity using TMS measures

Sponsors

Institut National de la Santé Et de la Recherche Médicale, France
Lead SponsorOTHER_GOV

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Between group comparison

Eligibility

Sex/Gender
ALL
Age
13 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* Tourette syndrome * Ages 13 - 18 * Acceptance to perform the Brain MRI * Acceptance to perform the cognitive testing * Acceptance to perform the TMS measures

Exclusion criteria

* Learning disability * Incompatibility with MRI procedure (metal body implants, pregnancy)

Design outcomes

Primary

MeasureTime frameDescription
Behavioral test main outcome measures [1]from 16 to 20 monthsreaction times
Behavioral test main outcome measures [2]from 16 to 20 monthsdiscounting factor
Behavioral test main outcome measures [3]from 16 to 20 monthsnumber of premature responses
Behavioral test main outcome measures [4]from 16 to 20 monthsagency composite scores
Brain MRI scan measuresfrom 16 to 20 monthswhole brain structural connectivity, whole brain functional connectivity, brain cortical and subcortical structures volumes and morphology
Transcranial magnetic stimulationfrom 16 to 20 monthsShort Intracortical Inhibition (SICI) scores

Countries

France

Contacts

PRINCIPAL_INVESTIGATORWorbe Yulia, MD, PhD

Institut National de la Santé Et de la Recherche Médicale, France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 6, 2026